[HTML][HTML] Pre-clinical and clinical importance of miR-21 in human cancers: Tumorigenesis, therapy response, delivery approaches and targeting agents

M Hashemi, MSA Mirdamadi, Y Talebi… - Pharmacological …, 2023 - Elsevier
The field of non-coding RNA (ncRNA) has made significant progress in understanding the
pathogenesis of diseases and has broadened our knowledge towards their targeting …

Global research and emerging trends in autophagy in lung cancer: a bibliometric and visualized study from 2013 to 2022

BN Liu, J Chen, Y Piao - Frontiers in Pharmacology, 2024 - frontiersin.org
Purpose: To highlight the knowledge structure and evolutionary trends in research on
autophagy in lung cancer. Methods: Research publications on autophagy in lung cancer …

DSTYK inhibition increases the sensitivity of lung cancer cells to T cell–mediated cytotoxicity

K Valencia, M Echepare, Á Teijeira… - Journal of Experimental …, 2022 - rupress.org
Lung cancer remains the leading cause of cancer-related death worldwide. We identify
DSTYK, a dual serine/threonine and tyrosine non-receptor protein kinase, as a novel …

FAT4 activation inhibits epithelial-mesenchymal transition (EMT) by promoting autophagy in H2228/Cer cells

Y Yang, Y Li, Q Yang, Z Liu, X Chang, H Yang, J Liu… - Medical Oncology, 2022 - Springer
As a tumor suppressor in lung cancer, FAT atypical cadherin 4 (FAT4) has a critical role in
epithelial-mesenchymal transition (EMT). However, the role of FAT4 in ceritinib-resistant …

[HTML][HTML] Poor prognosis of oral squamous cell carcinoma correlates With ITGA6

C Zhang, Q Cai, J Ke - international dental journal, 2023 - Elsevier
Objectives Oral cancer is the ninth most common cancer worldwide and a leading cause of
cancer-related death. Oral squamous cell carcinoma (OSCC) accounts for 90% of all oral …

Deciphering the effects and mechanisms of Yi-Fei-San-Jie-pill on non-small cell lung cancer with integrating network target analysis and experimental validation

H Yang, Q Guo, J Wu, L Zhong, L Sun, W Liu… - Frontiers in …, 2022 - frontiersin.org
Non-small cell lung cancer (NSCLC), which accounts for 85% of lung cancer cases, calls for
better therapy. Yi-Fei-San-Jie-pill (YFSJ), a well-applicated traditional Chinese medicine …

Multi-Omics integration-based prioritisation of competing endogenous RNA regulation networks in small cell lung cancer: Molecular characteristics and drug …

XJ Wang, J Gao, Q Yu, M Zhang, WD Hu - Frontiers in oncology, 2022 - frontiersin.org
Background The competing endogenous RNA (ceRNA) network-mediated regulatory
mechanisms in small cell lung cancer (SCLC) remain largely unknown. This study aimed to …

[HTML][HTML] Controversies regarding transplantation of mesenchymal stem cells

T Velikova, T Dekova, DG Miteva - World Journal of Transplantation, 2024 - wjgnet.com
Mesenchymal stem cells (MSCs) have tantalized regenerative medicine with their
therapeutic potential, yet a cloud of controversies looms over their clinical tran splantation …

[PDF][PDF] 布托啡诺调节Wnt/β-catenin 信号通路对肺癌细胞增殖迁移和血管生成的影响

文竹, 陈婷婷 - 河北医学, 2024 - hbyxzzs.cn
布托啡诺调节Wnt / β-catenin 信号通路对肺癌细胞增殖迁移和血管生成的影响 Page 1 􀥝􀥝􀥝􀥝􀥝􀥝􀥝 􀥝􀥝 􀥝􀥝 􀥝􀥝 􀥝 􀧝 􀧝 􀧝 􀧝
论著 [文章编号] 1006-6233(2024)05-0705-06 布托啡诺调节Wnt / β-catenin 信号通路对肺癌 …

Cinobufotalin effect and mechanism on serum MMP-2, MMP-9, Beclin1, LC3-II in advanced NSCLC patients

L Yang, B Bai, H Chen, T Li, M Wang… - Cellular and Molecular …, 2023 - cellmolbiol.org
This study was conducted to explore cinobufotalin's effects and related mechanisms on
serum MMP-2, MMP-9, Beclin1, and LC3-II in advanced non-small-cell lung cancer …